Joining me on the call today is Victor Limongelli, our Chief Executive Officer, and Jorge Martell, our Chief Financial ...

Thank you, Eric. With me today are Mark Pytosh, our Chief Executive Officer, Dane Neumann, our Chief Financial Officer, and ...

Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) Q3 2025 Earnings Call Transcript October 30, 2025 Phathom Pharmaceuticals, Inc.

Q3 2025 Earnings Call Transcript October 30, 2025 Operator: “ Kristi Mussallem: “ Jason Serrano: “ Kristine Nario: “ Nicholas Mah: “ Bose George: ” Keefe, Bruyette, & Woods, Inc., Research Division ...

Increased 4.5% to $8.41 at the end of Q3 2025, reflecting gains across agency mortgage-backed securities. Economic return -- ...

Lumen Technologies focuses on digital growth through partnerships, strategic transformation, and discounted valuation. See why LUMN stock is a buy.

Berkshire Hathaway shows strong profit growth, solid insurance and railroad performance, and a powerful cash position. Find ...

Non-interest expense increased by $290,000 compared to the prior quarter, mainly due to higher professional fees, occupancy, ...

Coming up: earnings from AMD, Palantir, top pharmaceutical and tech firms; private-sector employment report; consumer sentiment.

Discover how the Magnificent 7 stocks and artificial intelligence demand fueled a record S&P 500 earnings surge in Q3 2025, ...